Actionable news
0
All posts from Actionable news
Actionable news in BLL: BALL CORPORATION,

Analysts' Actions — Bristol-Myers, Merck, JPMorgan, Weyerhaeuser and More

RATINGS CHANGES

Ball (BLL) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: BLL.

Bristol-Myers Squibb (BMY) was downgraded to neutral at Credit Suisse. $63 price target. Opdivo clinical failure for lung cancer was stunning, Credit Suisse said.

Dominion Resources (D) was downgraded to equal-weight from overweight at Morgan Stanley. The valuation is...


More